Feasibility, safety, and efficacy of a new percutaneous interspinous device: a retrospective multicenter study.

Purpose: To evaluate safety and efficacy of the novel percutaneous interspinous device (PID) for the treatment of symptomatic degenerative lumbar spinal stenosis (DLSS) in 3 different centers.

Methods: From November 2016 to March 2020, 255 patients (male 125, mean age 71.2 years old range 49-91 years old) with neurogenic claudication, confirmed by electromyography, related to mono or bi-segmental lumbar central canal and/or foraminal stenosis were enrolled in the study.

Percutaneous removal and replacement of a novel percutaneous interspinous device.

The aim of this study is to explain the technique used for removing and replacing a novel percutaneous interspinous device (PID). Three male patients, with a mean age of 66 years (range 62-72), were included in the study due to displacement ( = 2) or misplacement ( = 1) of the novel PID. This occurred after a mean of 23.

Results of an International Survey on Spinal Imaging by the ASNR/ASSR/ESNR/ESSR "Nomenclature 3.0" Working Group.

Our goal was to determine if "Nomenclature 2.0," the classification of lumbar disk pathology consensus, should be updated. We conducted a social media and e-mail-based survey on preferences regarding the use of classification on magnetic resonance spine reporting.